Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata
Trial details
- Registry ID
- NCT05589610
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia AreataNCT05589610 | Equillium | Phase 2 | Completed | 2024-03-26Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |